PL2963006T3 - Kompozycja zawierająca chinon alfa-tokotrienolu, i jego związki pośrednie - Google Patents

Kompozycja zawierająca chinon alfa-tokotrienolu, i jego związki pośrednie

Info

Publication number
PL2963006T3
PL2963006T3 PL15175938T PL15175938T PL2963006T3 PL 2963006 T3 PL2963006 T3 PL 2963006T3 PL 15175938 T PL15175938 T PL 15175938T PL 15175938 T PL15175938 T PL 15175938T PL 2963006 T3 PL2963006 T3 PL 2963006T3
Authority
PL
Poland
Prior art keywords
intermediates
composition containing
containing alpha
tocotrienol quinone
tocotrienol
Prior art date
Application number
PL15175938T
Other languages
English (en)
Polish (pl)
Inventor
Kieron E. Wesson
Andrew W. Hinman
Orion D. Jankowski
Original Assignee
Bioelectron Technology Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioelectron Technology Corporation filed Critical Bioelectron Technology Corporation
Publication of PL2963006T3 publication Critical patent/PL2963006T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/723,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00Preparation of quinones
    • C07C46/02Preparation of quinones by oxidation giving rise to quinoid structures
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00Preparation of quinones
    • C07C46/02Preparation of quinones by oxidation giving rise to quinoid structures
    • C07C46/06Preparation of quinones by oxidation giving rise to quinoid structures of at least one hydroxy group on a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15175938T 2008-10-28 2009-10-27 Kompozycja zawierająca chinon alfa-tokotrienolu, i jego związki pośrednie PL2963006T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19758508P 2008-10-28 2008-10-28
EP09824070.8A EP2362875B1 (en) 2008-10-28 2009-10-27 Process for the production of alpha-tocotrienol and derivatives
EP15175938.8A EP2963006B1 (en) 2008-10-28 2009-10-27 Composition containing alpha-tocotrienol quinone,and intermediates thereof
PCT/US2009/062212 WO2010051277A1 (en) 2008-10-28 2009-10-27 Process for the production of alpha-tocotrienol and derivatives

Publications (1)

Publication Number Publication Date
PL2963006T3 true PL2963006T3 (pl) 2019-01-31

Family

ID=42118126

Family Applications (2)

Application Number Title Priority Date Filing Date
PL15175938T PL2963006T3 (pl) 2008-10-28 2009-10-27 Kompozycja zawierająca chinon alfa-tokotrienolu, i jego związki pośrednie
PL09824070T PL2362875T3 (pl) 2008-10-28 2009-10-27 Proces do wytwarzania alfa-tokotrienolu i pochodnych

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL09824070T PL2362875T3 (pl) 2008-10-28 2009-10-27 Proces do wytwarzania alfa-tokotrienolu i pochodnych

Country Status (17)

Country Link
US (6) US8106223B2 (enExample)
EP (3) EP2963006B1 (enExample)
JP (7) JP5775459B2 (enExample)
CN (2) CN105753829B (enExample)
BR (1) BRPI0920414B1 (enExample)
CA (2) CA2974482C (enExample)
DK (2) DK2362875T3 (enExample)
EA (2) EA201692046A1 (enExample)
ES (2) ES2701260T3 (enExample)
HU (1) HUE041714T2 (enExample)
MX (1) MX2011004440A (enExample)
MY (2) MY185183A (enExample)
PL (2) PL2963006T3 (enExample)
PT (2) PT2963006T (enExample)
SI (1) SI2963006T1 (enExample)
TR (1) TR201819154T4 (enExample)
WO (1) WO2010051277A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050065099A1 (en) 2003-09-19 2005-03-24 Gail Walkinshaw Treatment of mitochondrial diseases
PT2471530T (pt) 2005-06-01 2017-04-19 Edison Pharmaceuticals Inc Produtos terapêuticos com atividade redox para o tratamento de doenças mitocondriais e de outras condições e modulação de biomarcadores energéticos
EP1986636B1 (en) 2006-02-22 2013-04-24 Edison Pharmaceuticals, Inc. Phenol and 1,4-benzoquinone derivatives for use in the treatment of mitochondrial diseases
EP3456707B1 (en) 2007-11-06 2020-04-15 PTC Therapeutics, Inc. 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
JP5649454B2 (ja) * 2008-01-08 2015-01-07 エジソン ファーマシューティカルズ, インコーポレイテッド ミトコンドリア病の処置のための(ヘテロ)アリール−p−キノン誘導体
EP2262508B1 (en) 2008-03-05 2018-10-03 BioElectron Technology Corporation SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
EP2303824B1 (en) * 2008-06-25 2015-03-25 Edison Pharmaceuticals, Inc. 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
US8314153B2 (en) 2008-09-10 2012-11-20 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
EP2362726B1 (en) 2008-10-14 2018-08-08 Bioelectron Technology Corporation Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
PT2963006T (pt) 2008-10-28 2018-12-14 Bioelectron Tech Corp Composição contendo alfa-tocotrienol quinona e seus intermediários
PL2424495T3 (pl) 2009-04-28 2018-06-29 Bioelectron Technology Corporation Leczenie dziedzicznej neuropatii nerwów wzrokowych lebera i dominującego zaniku nerwu wzrokowego chinonami tokotrienolu
SI2470168T1 (en) * 2009-08-26 2018-05-31 Bioelectron Technology Corporation Procedures for the prevention and treatment of brain ischemia
WO2012154613A1 (en) * 2011-05-06 2012-11-15 Edison Pharmaceuticals, Inc. Improved process for the preparation of d-alpha-tocotrienol from natural extracts
WO2012174286A1 (en) 2011-06-14 2012-12-20 Edison Pharmaceuticals, Inc. Catechol derivatives for treatment of oxidative stress diseases
WO2013013078A1 (en) 2011-07-19 2013-01-24 Edison Pharmeceuticals, Inc. Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols
MY162508A (en) * 2011-07-21 2017-06-15 Sime Darby Malaysia Berhad External preparation for skin
US9629815B2 (en) 2012-09-07 2017-04-25 Bioelectron Technology Corporation Benzoquinone derivatives for treating oxidative stress disorders
US8937191B2 (en) * 2012-12-20 2015-01-20 Orochem Technologies, Inc. Recovery of highly pure alpha-tocotrienol from crude palm oil extract
US9670170B2 (en) 2013-03-15 2017-06-06 Bioelectron Technology Corporation Resorufin derivatives for treatment of oxidative stress disorders
US9868711B2 (en) 2013-03-15 2018-01-16 Bioelectron Technology Corporation Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
US10189830B2 (en) 2013-03-15 2019-01-29 Bioelectron Technology Corporation Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders
US9296712B2 (en) 2013-03-15 2016-03-29 Edison Pharmaceuticals, Inc. Resorufin derivatives for treatment of oxidative stress disorders
CN106414580A (zh) * 2013-11-29 2017-02-15 沙特基础工业公司 稳定化的聚烯烃组合物
US9512098B1 (en) 2014-02-03 2016-12-06 Board Of Trustees Of The University Of Arkansas Process of producing purified gamma- and delta-tocotrienols from tocol-rich oils or distillates
CN104262315A (zh) * 2014-09-05 2015-01-07 宁波大红鹰生物工程股份有限公司 一种生育三烯酚的分离提纯方法
BR112017012988B1 (pt) 2014-12-16 2023-10-03 Ptc Therapeutics, Inc Formas polimoráficas e amorfas de (r)-2-hidroxi-2- metil-4- (2,4,5-trimetil-3,6-dioxociclohexa-1,4-dienil) butanamida
JP2018502127A (ja) 2015-01-12 2018-01-25 バイオエレクトロン テクノロジー コーポレイション 放射線被曝に対する防護のためのキノン
WO2017106786A1 (en) * 2015-12-16 2017-06-22 Bioelectron Technology Corporation Improved methods for enriching alpha-tocotrienol from mixed tocol compositions
WO2017106803A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
WO2017123822A1 (en) 2016-01-12 2017-07-20 Bioelectron Technology Corporation Tocopherol and tocotrienol quinone derivatives for increasing thiosulfate levels or decreasing hydrogen sulfide levels
JP2018083799A (ja) 2016-11-15 2018-05-31 バイオエレクトロン テクノロジー コーポレイション 2−置換アミノ−ナフト[1,2−d]イミダゾール−5−オン化合物またはその製薬学上許容される塩
WO2018191732A1 (en) 2017-04-14 2018-10-18 Bioelectron Technology Corporation Methods and compositions for treatment of inflammation and oxidative stress
MX2021004329A (es) 2018-10-17 2021-06-08 Ptc Therapeutics Inc 2,3,5-trimetil-6-nonilciclohexa-2,5-dien-1,4-diona para suprimir y tratar alfa-sinucleinopatias, tauopatias y otros trastornos.
US11584728B2 (en) 2019-10-04 2023-02-21 Stealth Biotherapeutics Inc. Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia
CN121085756A (zh) 2020-04-03 2025-12-09 康德生物医疗有限公司 用于预防和/或治疗线粒体疾病的组合物和方法
MX2024000445A (es) 2021-07-08 2024-04-05 Ptc Therapeutics Inc Composiciones farmaceuticas que comprenden 2,3,5-trimetil-6-nonilc iclohexa-2,5-dieno-1,4-diona.

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2519863A (en) 1949-05-14 1950-08-22 Eastman Kodak Co Conversion of beta-, gamma-, and delta-tocopherol to alpha-tocopherol by aminoalkylation and reduction
US4977282A (en) 1984-04-17 1990-12-11 Henkel Corporation Production of d-alpha-tocopherol from natural plant sources
AU581216B2 (en) * 1984-04-17 1989-02-16 Henkel Corporation Production of d-alpha-tocopherol from natural plant sources
US4603142A (en) 1984-06-01 1986-07-29 Wisconsin Alumni Research Foundation Cholesterol lowering method of use
JPS636186A (ja) 1986-06-23 1988-01-12 タツタ電線株式会社 点滴監視装置
JPH0788376B2 (ja) 1986-09-02 1995-09-27 エーザイ株式会社 光学活性α−トコトリエノ−ルの製造方法
JP2685785B2 (ja) 1988-03-11 1997-12-03 エーザイ株式会社 光学活性α−トコトリエノールの製造方法
AU618791B2 (en) 1988-03-16 1992-01-09 Bioindustry Development Centre Production of high concentration tocopherols and tocotrienols from palm oil by-product
US5157132A (en) * 1990-05-18 1992-10-20 Carotech Associates Integrated process for recovery of carotenoids and tocotrienols from oil
JPH07504887A (ja) 1991-11-22 1995-06-01 リポジェニックス,インコーポレイテッド トコトリエノールおよびトコトリエノール様化合物ならびにこれらを使用する方法
DE59605564D1 (de) 1995-03-28 2000-08-17 Hoffmann La Roche Aminomethylierung von Tocopherolen
US5660691A (en) 1995-11-13 1997-08-26 Eastman Chemical Company Process for the production of tocotrienol/tocopherol blend concentrates
US6232060B1 (en) 1996-01-19 2001-05-15 Galileo Laboratories, Inc. Assay system for anti-stress agents
US5801159A (en) 1996-02-23 1998-09-01 Galileo Laboratories, Inc. Method and composition for inhibiting cellular irreversible changes due to stress
US5932748A (en) 1997-06-06 1999-08-03 Roche Vitamins Inc. Process for permethylating non-α-tocopherols to produce α-tocopherol
DE69814163T2 (de) * 1997-10-29 2004-02-12 Flexsys America L.P., Akron Herstellung von chinondiiminen aus phenylendiaminen unter verwendung von wasserstoffperoxid als katalysator
EP1051412B1 (en) 1998-01-29 2003-09-24 Eastman Chemical Company Methods for separating a tocotrienol from a tocol-containing mixture and compositions thereof
MY125803A (en) 1998-11-06 2006-08-30 Fuji Chem Ind Co Ltd A tocotrienol-containing powder, a process for preparing it and a tablet comprising compressed said powder into a tablet form
US6395915B1 (en) 1999-09-10 2002-05-28 Technikrom, Inc. Method for producing purified tocotrienols and tocopherols using liquid chromatography
MY127451A (en) 1999-11-04 2006-12-29 Malaysian Palm Oil Board A method of chromatographic isolation for vitamin e isomers
DE10034233A1 (de) * 2000-07-14 2002-01-24 Basf Ag Tocotrienolchinon-Cyclisierungsprodukte
US7034054B2 (en) 2000-12-15 2006-04-25 Galileo Pharmaceuticals, Inc. Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols
US6838104B2 (en) 2000-12-20 2005-01-04 Archer Daniels Midland Company Process for the production of tocotrienols
US6608196B2 (en) 2001-05-03 2003-08-19 Galileo Pharmaceuticals, Inc. Process for solid supported synthesis of pyruvate-derived compounds
JP4842455B2 (ja) 2001-06-13 2011-12-21 コマツNtc株式会社 半導体単結晶引上げ装置及びそのライン構成
JP2003171376A (ja) 2001-09-27 2003-06-20 Lion Corp トコフェロール類及びトコトリエノール類濃縮物、その製造方法
US6667330B2 (en) 2002-01-31 2003-12-23 Galileo Pharmaceuticals, Inc. Furanone derivatives
US6653346B1 (en) 2002-02-07 2003-11-25 Galileo Pharmaceuticals, Inc. Cytoprotective benzofuran derivatives
US6590113B1 (en) 2002-03-26 2003-07-08 Ronald T. Sleeter Process for treating oils containing antioxidant compounds
WO2004042353A2 (en) 2002-10-30 2004-05-21 Galileo Pharmaceuticals, Inc. Identifying therapeutic compounds based on their physical-chemical properties
MY130618A (en) 2002-11-27 2007-07-31 Malaysian Palm Oil Board A method of extracting and isolating minor components from vegetable oil
US20050065099A1 (en) 2003-09-19 2005-03-24 Gail Walkinshaw Treatment of mitochondrial diseases
WO2005035490A2 (en) 2003-10-10 2005-04-21 Yasoo Health, Inc. PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS
MY173044A (en) 2003-11-19 2019-12-20 Carotech Bhd Recovery of phytonutriens from oils
US7393662B2 (en) 2004-09-03 2008-07-01 Centocor, Inc. Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
PT2471530T (pt) 2005-06-01 2017-04-19 Edison Pharmaceuticals Inc Produtos terapêuticos com atividade redox para o tratamento de doenças mitocondriais e de outras condições e modulação de biomarcadores energéticos
JP2009508867A (ja) 2005-09-15 2009-03-05 エジソン ファーマシューティカルズ, インコーポレイテッド ミトコンドリア病および関連した様態の治療ならびにエネルギーバイオマーカーの調節のための酸化還元活性治療剤のテイル改変体
EP1986636B1 (en) 2006-02-22 2013-04-24 Edison Pharmaceuticals, Inc. Phenol and 1,4-benzoquinone derivatives for use in the treatment of mitochondrial diseases
WO2007105297A1 (ja) * 2006-03-13 2007-09-20 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo メチン系色素とその用途
AU2008205263A1 (en) 2007-01-10 2008-07-17 Edison Pharmaceuticals, Inc. Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity
WO2008142433A1 (en) 2007-05-24 2008-11-27 Loders Croklaan B.V. Process for producing compositions comprising tocoherols and tocotrienols
EP3456707B1 (en) 2007-11-06 2020-04-15 PTC Therapeutics, Inc. 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
CA2710253A1 (en) 2008-01-07 2009-07-16 Centocor Ortho Biotech Inc. Method of treating erythropoietin hyporesponsive anemias
JP5649454B2 (ja) 2008-01-08 2015-01-07 エジソン ファーマシューティカルズ, インコーポレイテッド ミトコンドリア病の処置のための(ヘテロ)アリール−p−キノン誘導体
CA2717741C (en) * 2008-03-05 2018-04-03 Ptc Therapeutics, Inc. Treatment of hearing and balance impairments with redox-active therapeutics
EP2262508B1 (en) 2008-03-05 2018-10-03 BioElectron Technology Corporation SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
EP2310038A4 (en) 2008-05-15 2012-03-14 Edison Pharmaceuticals Inc TREATMENT OF HEARING AND BALANCE OF IMPROVENCE WITH COMPOUNDS WITH ERYTHROPOETIN EFFECT
EP2303309A2 (en) 2008-05-22 2011-04-06 Edison Pharmaceuticals, Inc. Treatment of mitochondrial diseases with an erythropoietin mimetic
EP2303824B1 (en) 2008-06-25 2015-03-25 Edison Pharmaceuticals, Inc. 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
US20100010100A1 (en) 2008-07-09 2010-01-14 Hinman Andrew W Dermatological compositions with anti-aging and skin even-toning properties
WO2010014361A1 (en) 2008-07-30 2010-02-04 Edison Pharmaceuticals, Inc. Naphthoquinone compositions with anti-aging, anti- inflammatory and skin even-toning properties
WO2010014758A1 (en) 2008-07-30 2010-02-04 Edison Pharmaceuticals, Inc. Use of hydrogenated pyrido[4,3-b] indoles for the treatment of oxidative stress
US8314153B2 (en) * 2008-09-10 2012-11-20 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
EP2362726B1 (en) 2008-10-14 2018-08-08 Bioelectron Technology Corporation Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
PT2963006T (pt) 2008-10-28 2018-12-14 Bioelectron Tech Corp Composição contendo alfa-tocotrienol quinona e seus intermediários
WO2010126909A1 (en) 2009-04-28 2010-11-04 Edison Pharmaceuticals, Inc. Formulation of tocotrienol quinones for the treatment of ophthalmic diseases
US20120136048A1 (en) 2009-04-28 2012-05-31 Miller Guy M Topical, periocular, or intraocular use of tocotrienols for the treatment of ophthalmic diseases
PL2424495T3 (pl) 2009-04-28 2018-06-29 Bioelectron Technology Corporation Leczenie dziedzicznej neuropatii nerwów wzrokowych lebera i dominującego zaniku nerwu wzrokowego chinonami tokotrienolu
MX2011013558A (es) 2009-06-25 2012-04-30 Ampere Life Sciences Inc Tratamiento del trastorno pervasivo del desarrollo con tocotrienoles o extractos de tocotrienoles enriquecidos.
SI2470168T1 (en) 2009-08-26 2018-05-31 Bioelectron Technology Corporation Procedures for the prevention and treatment of brain ischemia
EP2519232A1 (en) 2009-12-31 2012-11-07 Edison Pharmaceuticals, Inc. Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones
EP2545025A1 (en) 2010-03-09 2013-01-16 Edison Pharmaceuticals, Inc. Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same
WO2011113018A1 (en) 2010-03-12 2011-09-15 Ampere Life Sciences, Inc. Measurement and control of biological time
US20130116336A1 (en) 2010-04-06 2013-05-09 William D. Shrader Treatment of ataxia telangiectasia
CA2797581A1 (en) 2010-04-27 2011-11-03 Edison Pharmaceuticals, Inc. Formulations of quinones for the treatment of ophthalmic diseases
WO2012009271A1 (en) 2010-07-14 2012-01-19 Penwest Pharmaceuticals Co. Methods of providing anticoagulation effects in subjects
SG187744A1 (en) 2010-08-06 2013-03-28 Edison Pharmaceuticals Inc Treatment of mitochondrial diseases with naphthoquinones
US20120295985A1 (en) 2010-11-19 2012-11-22 Miller Guy M Methods for improving blood glucose control
WO2012154613A1 (en) 2011-05-06 2012-11-15 Edison Pharmaceuticals, Inc. Improved process for the preparation of d-alpha-tocotrienol from natural extracts
WO2012170773A1 (en) 2011-06-08 2012-12-13 Edison Pharmaceuticals, Inc. Adjunctive therapy for the treatment of mitochondrial disorders with quinones and naphthoquinones
WO2012174286A1 (en) 2011-06-14 2012-12-20 Edison Pharmaceuticals, Inc. Catechol derivatives for treatment of oxidative stress diseases
WO2013006736A1 (en) 2011-07-06 2013-01-10 Edison Pharmaceuticals, Inc Treatment of leigh syndrome and leigh-like syndrome, including complications of sucla2 mutations, with tocotrienol quinones
ES2795798T3 (es) 2011-07-06 2020-11-24 Ptc Therapeutics Inc Tratamiento de aciduria metilmalónica, aciduria isovalérica, y otras acidurias orgánicas con tocotrienol quinonas
WO2013013078A1 (en) 2011-07-19 2013-01-24 Edison Pharmeceuticals, Inc. Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols
US9629815B2 (en) 2012-09-07 2017-04-25 Bioelectron Technology Corporation Benzoquinone derivatives for treating oxidative stress disorders
US8937191B2 (en) 2012-12-20 2015-01-20 Orochem Technologies, Inc. Recovery of highly pure alpha-tocotrienol from crude palm oil extract
EA031098B1 (ru) 2013-03-08 2018-11-30 Юнилевер Н.В. Соединения резорцина для дерматологического применения
US20140275045A1 (en) 2013-03-15 2014-09-18 Edison Pharmaceuticals, Inc. Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
US9296712B2 (en) 2013-03-15 2016-03-29 Edison Pharmaceuticals, Inc. Resorufin derivatives for treatment of oxidative stress disorders
US10189830B2 (en) 2013-03-15 2019-01-29 Bioelectron Technology Corporation Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders
US9670170B2 (en) 2013-03-15 2017-06-06 Bioelectron Technology Corporation Resorufin derivatives for treatment of oxidative stress disorders
US9868711B2 (en) 2013-03-15 2018-01-16 Bioelectron Technology Corporation Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
AU2014273891A1 (en) 2013-05-31 2015-12-24 Bioelectron Technology Corporation Carboxylic acid derivatives for treatment of oxidative stress disorders
BR112017012988B1 (pt) 2014-12-16 2023-10-03 Ptc Therapeutics, Inc Formas polimoráficas e amorfas de (r)-2-hidroxi-2- metil-4- (2,4,5-trimetil-3,6-dioxociclohexa-1,4-dienil) butanamida
US20180002247A1 (en) 2014-12-16 2018-01-04 Bioelectron Technology Corporation Methods for chiral resolution of trolox
JP2018502127A (ja) 2015-01-12 2018-01-25 バイオエレクトロン テクノロジー コーポレイション 放射線被曝に対する防護のためのキノン
WO2017106786A1 (en) 2015-12-16 2017-06-22 Bioelectron Technology Corporation Improved methods for enriching alpha-tocotrienol from mixed tocol compositions
WO2017106803A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
WO2017123823A1 (en) 2016-01-12 2017-07-20 Bioelectron Technology Corporation Alkyl-, acyl-, urea-, and aza-uracil sulfide:quinone oxidoreductase inhibitors
WO2017123822A1 (en) 2016-01-12 2017-07-20 Bioelectron Technology Corporation Tocopherol and tocotrienol quinone derivatives for increasing thiosulfate levels or decreasing hydrogen sulfide levels
US20190241497A1 (en) 2016-10-28 2019-08-08 Andrew W. Hinman Methods for analyzing p-hydroquinone levels and ratios
WO2018093957A1 (en) 2016-11-15 2018-05-24 Bioelectron Technology Corporation 2-substituted amino-naphth[1,2-d]imidazol-5-one compounds or pharmaceutically acceptable salts thereof cross reference to related applications
WO2018129411A1 (en) 2017-01-06 2018-07-12 Bioelectron Technology Corporation Aryl- and heteroaryl-resorufin derivatives for treatment of oxidative stress disorders and liver and kidney disorders
WO2018191732A1 (en) 2017-04-14 2018-10-18 Bioelectron Technology Corporation Methods and compositions for treatment of inflammation and oxidative stress

Also Published As

Publication number Publication date
SI2963006T1 (sl) 2019-01-31
JP2023073469A (ja) 2023-05-25
US10071978B2 (en) 2018-09-11
JP2019065041A (ja) 2019-04-25
CN102264730B (zh) 2016-04-13
EP3450431B1 (en) 2023-09-13
CA2741767C (en) 2017-09-12
US20220204469A1 (en) 2022-06-30
HK1219718A1 (en) 2017-04-13
EP2963006A1 (en) 2016-01-06
WO2010051277A1 (en) 2010-05-06
JP2021066745A (ja) 2021-04-30
EA201100699A1 (ru) 2011-12-30
JP7181708B2 (ja) 2022-12-01
BRPI0920414A2 (pt) 2015-08-04
BRPI0920414B1 (pt) 2018-05-22
JP2015187169A (ja) 2015-10-29
PL2362875T3 (pl) 2016-01-29
CN102264730A (zh) 2011-11-30
EP2963006B1 (en) 2018-10-17
PT2362875E (pt) 2015-11-03
CA2974482A1 (en) 2010-05-06
US20170037023A1 (en) 2017-02-09
EP2362875A1 (en) 2011-09-07
US11312697B2 (en) 2022-04-26
ES2701260T3 (es) 2019-02-21
US8106223B2 (en) 2012-01-31
MY185183A (en) 2021-04-30
TR201819154T4 (tr) 2019-01-21
MX2011004440A (es) 2011-06-20
CA2974482C (en) 2019-10-29
CN105753829A (zh) 2016-07-13
HK1161876A1 (en) 2012-08-10
US20120130093A1 (en) 2012-05-24
HUE041714T2 (hu) 2019-05-28
EA201692046A1 (ru) 2017-06-30
JP6001025B2 (ja) 2016-10-05
US8575369B2 (en) 2013-11-05
JP2014221842A (ja) 2014-11-27
EP2362875A4 (en) 2012-06-27
JP2012506910A (ja) 2012-03-22
JP5775459B2 (ja) 2015-09-09
DK2362875T3 (en) 2015-11-30
MY157119A (en) 2016-05-13
EA026417B1 (ru) 2017-04-28
EP2362875B1 (en) 2015-08-19
EP3450431A1 (en) 2019-03-06
JP2018135394A (ja) 2018-08-30
WO2010051277A8 (en) 2011-01-27
CN105753829B (zh) 2019-02-01
CA2741767A1 (en) 2010-05-06
PT2963006T (pt) 2018-12-14
US20100105930A1 (en) 2010-04-29
ES2553557T3 (es) 2015-12-10
US20190002428A1 (en) 2019-01-03
DK2963006T3 (en) 2019-01-14
US20140221674A1 (en) 2014-08-07

Similar Documents

Publication Publication Date Title
PL2963006T3 (pl) Kompozycja zawierająca chinon alfa-tokotrienolu, i jego związki pośrednie
IL239833A0 (en) Iminothiadiazine dioxide compounds, their preparations and uses
SI2719699T1 (sl) Določeni triazolopirazini, njihovi sestavki in načini njihove uporabe
IL215684A0 (en) Trehalulose-containing composition, its preparation and use
EP2307344A4 (en) OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, PREPARATION AND USE THEREOF
EP2445067A4 (en) COMPOSITION FOR FILLING THE DISCHARGE GAP AND ELECTROSTATIC DISCHARGE PROTECTION
ZA201108292B (en) New compounds,pharmaceutical composition and methods relating thereto
PL2128199T3 (pl) Nowa kompozycja
GB0806978D0 (en) Novel formulations
GB0814728D0 (en) New combination
ZA201101520B (en) Phenanthrenone compounds,compositions and methods
PL2376479T3 (pl) Podstawione furanokarboksyamidy i ich zastosowanie
GB0823140D0 (en) New combination
GB0811100D0 (en) New combination
GB0814729D0 (en) New combination
GB0801122D0 (en) Vaccine composition
GB0906434D0 (en) New use
GB0823141D0 (en) New combination
GB0800414D0 (en) Novel use
GB0901227D0 (en) Composition,method and use
GB0901293D0 (en) Composition, method and use
GB0901234D0 (en) Composition,method and use
GB0819465D0 (en) Multiparticulate composition
GB0809774D0 (en) New use
GB0807591D0 (en) New use